Drug repurposing is undervalued, but it offers potential benefits for patients and healthcare systems, argue Ruth Langley and colleagues Drug repurposing involves finding new indications for ...

Treatment with 300 mg IV eptinezumab in adults with chronic migraine resulted in rapid and sustained reduction in the number of headache days that was largely sustained up to 84 weeks, according to a ...